awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33760578-F4586A8F-0250-46D1-9868-25CD901BC826
Q33760578-F4586A8F-0250-46D1-9868-25CD901BC826
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33760578-F4586A8F-0250-46D1-9868-25CD901BC826
Biomarker Development for the Clinical Activity of the mTOR Inhibitor Everolimus (RAD001): Processes, Limitations, and Further Proposals
P2860
Q33760578-F4586A8F-0250-46D1-9868-25CD901BC826
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33760578-F4586A8F-0250-46D1-9868-25CD901BC826
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
74d60e78aa7c8e5d666de2758c2038dbcb4b8e43
P2860
A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer.